Structure Database (LMSD)
Common Name
PE-N[FA 20:4(5Z,8Z,11Z,14Z)] P-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)
Systematic Name
1-(1Z-octadecenyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phospho-N-5Z,8Z,11Z,14Z-eicosatetraenoyl-ethanolamine
Synonyms
- 1-(1Z-octadecenyl)-2-(cervonoyl)-sn-glycero-3-phospho-N-arachidonoyl-ethanolamine
- NAPE(P-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
LM ID
LMGP02030103
Formula
Exact Mass
Calculate m/z
1061.781257
Sum Composition
Status
Active
No other lipid differing only in stereochemistry/bond geometry found
3D model of PE-N[FA 20:4(5Z,8Z,11Z,14Z)] P-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)
Please note: Where there are chiral atoms but the stereochemistry is undefined, the 3D model takes an arbitrary conformation
Classification
Category
Main Class
Sub Class
References
String Representations
InChiKey (Click to copy)
QVJRXFBVFSKKBZ-JMIYRCTQSA-N
InChi (Click to copy)
InChI=1S/C65H108NO8P/c1-4-7-10-13-16-19-22-25-28-31-32-34-36-39-42-45-48-51-54-57-65(68)74-63(61-71-59-55-52-49-46-43-40-37-30-27-24-21-18-15-12-9-6-3)62-73-75(69,70)72-60-58-66-64(67)56-53-50-47-44-41-38-35-33-29-26-23-20-17-14-11-8-5-2/h7,10,16-17,19-20,25-26,28-29,32,34-35,38-39,42,44,47-48,51,55,59,63H,4-6,8-9,11-15,18,21-24,27,30-31,33,36-37,40-41,43,45-46,49-50,52-54,56-58,60-62H2,1-3H3,(H,66,67)(H,69,70)/b10-7-,19-16-,20-17-,28-25-,29-26-,34-32-,38-35-,42-39-,47-44-,51-48-,59-55-/t63-/m1/s1
SMILES (Click to copy)
[C@](COP(=O)(O)OCCNC(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)=O)([H])(OC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)CO/C=C\CCCCCCCCCCCCCCCC
Other Databases
PubChem CID
Calculated Physicochemical Properties
Heavy Atoms
75
Rings
Aromatic Rings
Rotatable Bonds
55
Van der Waals Molecular Volume
1199.89
Topological Polar Surface Area
120.39
Hydrogen Bond Donors
2
Hydrogen Bond Acceptors
9
logP
20.77
Molar Refractivity
322.83
Admin
Created at
10th Oct 2023
Updated at
10th Oct 2023
LIPID MAPS® abbreviations for glycerophospholipids (GP)
The LIPID MAPS® glycerophospholipid abbreviations (PC, PE, etc.) are used here to refer to species with one or two radyl side-chains where the structures of the side chains are indicated within parentheses in the 'Headgroup(sn1/sn2)' format (e.g. PC(16:0/18:1(9Z)). By default, R stereochemistry at the C-2 carbon of glycerol and attachment of the headgroup at the sn3 position is assumed. Also, acyl chains are assumed by default. The 'O-' prefix is used to indicate the presence of an alkyl ether substituent e.g. PC(O-16:0/18:1(9Z)), whereas the 'P-' prefix is used for the 1Z-alkenyl ether (Plasmalogen) substituent e.g. PC(P-16:0/18:1(9Z)).
For molecules with opposite (S) stereochemistry at C2 of the glycerol group and attachment of the headgroup at the sn1 position, the stereochemistry specification of [S] is appended to the abbreviation. The 'Headgroup(sn3/sn2)' abbreviation format is used.
For molecules with unknown stereochemistry at the C-2 carbon of the glycerol group, the stereochemistry specification of [U] is appended to the abbreviation and the structure is drawn with C-2 stereochemistry unspecified.
The LIPID MAPS® glycerophospholipid abbreviations (PC, PE, etc.) are used here to refer to species with one or two radyl side-chains where the structures of the side chains are indicated within parentheses in the 'Headgroup(sn1/sn2)' format (e.g. PC(16:0/18:1(9Z)). By default, R stereochemistry at the C-2 carbon of glycerol and attachment of the headgroup at the sn3 position is assumed. Also, acyl chains are assumed by default. The 'O-' prefix is used to indicate the presence of an alkyl ether substituent e.g. PC(O-16:0/18:1(9Z)), whereas the 'P-' prefix is used for the 1Z-alkenyl ether (Plasmalogen) substituent e.g. PC(P-16:0/18:1(9Z)).
For molecules with opposite (S) stereochemistry at C2 of the glycerol group and attachment of the headgroup at the sn1 position, the stereochemistry specification of [S] is appended to the abbreviation. The 'Headgroup(sn3/sn2)' abbreviation format is used.
For molecules with unknown stereochemistry at the C-2 carbon of the glycerol group, the stereochemistry specification of [U] is appended to the abbreviation and the structure is drawn with C-2 stereochemistry unspecified.